Dr Christopher Gallen

Guest Contributor
July 16, 2004

Dr Christopher Gallen has been appointed president and CEO of Vancouver-based Neuromed Technologies Inc, a private biopharmaceutical firm focused on drugs for chronic pain. He replaces founding president

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.